Teladoc Health, Inc. (NYSE:TDOC) Insider Adam C. Vandervoort Sells 11,011 Shares

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) insider Adam C. Vandervoort sold 11,011 shares of Teladoc Health stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total value of $92,712.62. Following the transaction, the insider now owns 64,308 shares in the company, valued at approximately $541,473.36. The trade was a 14.62 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Teladoc Health Stock Up 5.3 %

Shares of NYSE TDOC traded up $0.45 during midday trading on Monday, hitting $8.86. The company's stock had a trading volume of 4,253,564 shares, compared to its average volume of 6,044,174. Teladoc Health, Inc. has a 1 year low of $6.76 and a 1 year high of $15.43. The business's fifty day simple moving average is $10.40 and its two-hundred day simple moving average is $9.77. The firm has a market capitalization of $1.54 billion, a price-to-earnings ratio of -1.53 and a beta of 1.27. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The business had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. On average, equities analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Remove Ads

Hedge Funds Weigh In On Teladoc Health

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Whipplewood Advisors LLC purchased a new stake in shares of Teladoc Health during the 4th quarter worth $29,000. Versant Capital Management Inc lifted its holdings in Teladoc Health by 313.8% during the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock worth $29,000 after buying an additional 2,441 shares during the last quarter. Lindbrook Capital LLC boosted its position in shares of Teladoc Health by 78.9% during the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock worth $33,000 after acquiring an additional 1,612 shares in the last quarter. Sterling Capital Management LLC boosted its position in shares of Teladoc Health by 776.7% during the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock worth $42,000 after acquiring an additional 4,101 shares in the last quarter. Finally, Pilgrim Partners Asia Pte Ltd purchased a new position in shares of Teladoc Health in the 4th quarter valued at about $60,000. Hedge funds and other institutional investors own 76.82% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have commented on TDOC shares. Royal Bank of Canada lifted their target price on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. Piper Sandler reduced their price target on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. The Goldman Sachs Group decreased their price objective on Teladoc Health from $16.00 to $13.00 and set a "buy" rating on the stock in a report on Monday, March 3rd. Bank of America raised their target price on Teladoc Health from $11.50 to $13.50 and gave the stock a "neutral" rating in a research note on Wednesday, February 12th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Teladoc Health in a research note on Thursday, February 27th. Eleven research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $11.26.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.